A patient's race/ethnicity does not explain the underuse of appropriate adjuvant therapy in colorectal cancer

Diseases of the Colon and Rectum

Volumn 49, Issue 3, 2006, Pages 319-329

  McGory, Marcia L ^a   Zingmond, David S ^a   Sekeris, Evan ^a   Bastani, Roshan ^b   Ko, Clifford Y ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Adjuvant therapy; Chemotherapy; Colorectal cancer; Disparities; Race ethnicity; Radiation therapy

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN AMERICAN; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COLORECTAL CANCER; COMORBIDITY; ETHNOLOGY; EUROPEAN AMERICAN; FEMALE; HEALTH CARE UTILIZATION; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; RACE; SOCIOECONOMICS; UNITED STATES;

AGE FACTORS; AGED; COHORT STUDIES; COLORECTAL NEOPLASMS; COMORBIDITY; CONTINENTAL POPULATION GROUPS; DATABASES; FEMALE; HUMANS; MALE; NEOADJUVANT THERAPY; POVERTY; REGISTRIES; REGRESSION ANALYSIS; SEX FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 33644971012     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-005-0283-6     Document Type: Article

References (29)

1. EE Partridge 1998 The National Cancer Data Base: ten years of growth and commitment CA Cancer J Clin 48 131 133
2. A Jemal T Murray E Ward 2005 Cancer statistics, 2005 CA Cancer J Clin 55 10 30
3. MD Abeloff JO Armitage AS Lichter FE Niederhuber 2000 Clinical oncology 2 Churchill Livingstone New York
4. NIH Consensus Conference 1990 Adjuvant therapy for patients with colon and rectal cancer JAMA 264 1444 1450
5. NIH Consensus Statements. Adjuvant therapy for patients with colon and rectum cancer. Available at: http://consensus.nih.gov/cons/079/079_statement. htm. Accessed April 8, 2005
6. SA Oliveria MU Yood UB Campbell SM Yood P Stang 2004 Treatment and referral patterns for colorectal cancer Med Care 42 901 906
7. D Schrag LD Cramer PB Bach CB Begg 2001 Age and adjuvant chemotherapy use after surgery for Stage III colon cancer J Natl Cancer Inst 93 850 857
8. AT Schroen RD Cress 2001 Use of surgical procedures and adjuvant therapy in rectal cancer treatment: a population-based study Ann Surg 234 641 651
9. AM Morris KG Billingsley NN Baxter LM Baldwin 2004 Racial disparities in rectal cancer treatment: a population-based analysis Arch Surg 139 151 155
10. VL Shavers ML Brown 2002 Racial and ethnic disparities in the receipt of cancer treatment J Natl Cancer Inst 94 334 357
11. JZ Ayanian AM Zaslavsky CS Fuchs 2003 Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort J Clin Oncol 21 1293 1300
12. AL Potosky LC Harlan RS Kaplan KA Johnson CF Lynch 2002 Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer J Clin Oncol 20 1192 1202
13. D Schrag SE Gelfand PB Bach J Guillem BD Minsky CB Begg 2001 Who gets adjuvant treatment for Stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results-Medicare J Clin Oncol 19 3712 3718
14. RG Roetzheim N Pal EC Gonzalez JM Ferrante DJ Van Durme JP Krischer 2000 Effects of health insurance and race on colorectal cancer treatments and outcomes Am J Public Health 90 1746 1754
15. California Cancer Registry. Available at: http://www.ccrcal.org. Accessed March 29, 2005
16. Office of Statewide Health Planning and Development (OSHPD). Available at: http://www.oshpd.cahwnet.gov/. Accessed January 19, 2005
17. Census 2000 Gateway. Available at: http://www.census.gov/main/www/ cen2000.html. Accessed March 29, 2005
18. ME Charlson P Pompei KL Ales CR [tmp] MacKenzie 1987 A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 373 383
19. RA Deyo DC Cherkin MA Ciol 1992 Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 613 619
20. W D'Hoore A Bouckaert C Tilquin 1996 Practical considerations on the use of the Charlson comorbidity index with administrative data bases J Clin Epidemiol 49 1429 1433
21. JA Meyerhardt RJ Mayer 2005 Systemic therapy for colorectal cancer N Engl J Med 352 476 487
22. R Sauer H Becker W Hohenberger 2004 Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731 1740
23. T Andre C Boni L Mounedji-Boudiaf 2004 Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2343 2351
24. JA Dominitz GP Samsa P Landsman D Provenzale 1998 Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system Cancer 82 2312 2320
25. SO Rogers WA Ray WE Smalley 2004 A population-based study of survival among elderly persons diagnosed with colorectal cancer: does race matter if all are insured? (United States) Cancer Causes Control 15 193 199
26. Swedish Rectal Cancer Trial 1997 Improved survival with preoperative radiotherapy in resectable rectal cancer NEngl J Med 336 980 987
27. EC Schneider AM Epstein JL Malin KL Kahn EJ Emanuel 2004 Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer care quality JClin Oncol 22 2985 2991
28. JZ Ayanian EA Chrischilles RH Fletcher 2004 Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium J Clin Oncol 22 2992 2996
29. ML [tmp] McGory PG Shekelle LZ Rubenstein A Fink CY Ko 2005 Developing quality indicators for elderly patients undergoing abdominal operations J Am Coll Surg 201 6 870 883